Pharmacy Practice and Pharmaceutical Sciences

01Purpose and scope

• This manual supports the course Pharmacy Practice and Pharmaceutical Sciences. It describes how the two halves of the discipline meet in daily work: the pharmacist who reviews an order, verifies a dose, counsels a patient, and documents the result, and the scientist or technician who understands how a dosage form is made, stored, and tested. It is a reference for practitioners, students in supervised placements, and staff who support pharmacy operations.
• Scope is limited to community, hospital, and ambulatory settings described in general terms. Practice details vary by jurisdiction, licensing board, facility policy, and drug class. Where a rule depends on location, check the current text from the state board of pharmacy, the national regulator, or the facility's approved procedures. This guidance does not replace qualified professional judgment, approved procedures, or required authorization.
• Within the field, pharmacy practice covers direct work with patients and prescribers, while pharmaceutical sciences covers the knowledge that makes that work reliable, including formulation, analytical testing, pharmacokinetics, and manufacturing. A hospital pharmacist who understands drug stability will know whether a crushed tablet can go through a feeding tube. A compounding technician who understands sterile technique will know why an expired diluent changes the beyond-use date. This manual treats both halves as one working system.

02Core principles

• Every medication decision has three parts: the patient, the drug product, and the setting. A correct drug at the wrong strength for a patient with reduced kidney function is still an error. Start by confirming who the patient is, exactly what the product is, and where the medicine will be given or used.
• Verification is a second, independent judgment, not a signature at the end of a queue. The verifier should be able to state what was checked: indication, dose, route, frequency, duration, interactions, allergies, and the product identifier or lot where relevant. Speed comes from clear routines, not from skipping checks.
• Pharmaceutical knowledge explains the exceptions. Extended-release products cannot be split or crushed without losing controlled release. Light-sensitive injections need protection during preparation. Excipients can matter for patients with specific allergies or for enteral tubes that clog. When the science and the order conflict, the pharmacist raises the question with the prescriber before any product is changed.
• Communication closes the loop. Counseling, handoff notes, and documentation are part of the medication process, not extras added afterward.

03Planning and preparation

• Before a service starts, define its scope. A community pharmacy filling routine prescriptions has different steps from a hospital unit preparing intravenous admixtures or a clinic running anticoagulation monitoring. Write down which activities the team performs, which need a licensed or credentialed person, and which require a written protocol or collaborative agreement where the jurisdiction allows one.
• Stakeholders usually include prescribers, nurses, patients and caregivers, pharmacy technicians, the supervising pharmacist or director, quality and risk staff, the formulary or therapeutics committee, wholesalers and distributors, and the regulatory body. Each group needs a clear contact route and a defined decision right. A technician should know when to escalate to the pharmacist, and a nurse should know who answers a question about a missed dose.
• Prepare the physical and digital environment. Confirm the stock list, storage conditions with temperature logs, controlled substance inventories, emergency kit contents, and the sterile compounding area if one is used. Confirm that the dispensing system or electronic health record displays allergies, weight, renal function, and recent laboratory values. Staff should be trained on current standard operating procedures before a new process goes live, and that training should be recorded.
• Trade-offs appear early. A small pharmacy may not justify a dedicated compounding room, so it may send sterile preparations to a contracted facility or limit the products it makes. A high-volume hospital may use barcode scanning with its own controls, while a rural clinic may rely on a paper checklist and a second staff member. Neither choice is wrong, but each has limits that should be written down.

04Recommended workflow

1. 1
   : Receive and identify the order. Confirm patient identity with two identifiers, such as full name and date of birth, and confirm the prescriber and the source of the order. Record whether the order is a new prescription, a refill, a transfer, or a verbal order, since each carries different requirements.
2. 2
   : Screen clinically. Review the indication, dose, route, frequency, duration, allergies, prior adverse reactions, current medications, and relevant laboratory values such as creatinine clearance, potassium, or liver enzymes. Check for duplicate therapy, interactions, and contraindications. Note any missing information and ask the prescriber before going further.
3. 3
   : Verify the product and the calculation. Confirm the drug, strength, dosage form, and concentration against the order. For weight-based or body-surface-based doses, recalculate independently and write the result down. For high-alert medicines such as insulin, heparin, concentrated potassium, and opioids, follow the facility's independent double-check procedure.
4. 4
   : Prepare or dispense. Select the product from stock, check the expiration date and lot, label the container, and prepare the dose. For compounded products, follow the approved formula, record components and lot numbers, and assign a beyond-use date that matches the stability data and the applicable standard. Use the environment required by the risk level of the preparation.
5. 5
   : Perform the final check. Compare the finished product and label with the original order. The final checker should look at the patient, drug, dose, route, directions, and auxiliary labels. Physical inspection matters as well, including clarity, particulates, color, and the integrity of the package.
6. 6
   : Counsel and hand off. Explain the purpose of the medicine, how to take or administer it, side effects that need a call, storage, and what to do about a missed dose. For inpatient transfers, send the reconciled medication list and any changes to the receiving team. Confirm understanding with teach-back where possible.
7. 7
   : Document and follow up. Record the intervention, the prescriber response, the counseling given, and any product substitution. Schedule follow-up where the plan needs it, such as a laboratory recheck, a titration visit, or a call about tolerance. Close the order only when the documentation supports the final state of the therapy.

05Quality checks, risk controls and compliance

• Quality checks sit inside the workflow and also run as periodic audits. Combine direct observation, record review, and sampling of finished products. Track the number of verified orders corrected after release, which is usually more useful than a raw count of total errors.
• Risk controls include barcode scanning at dispensing, tall-man lettering for look-alike names where the facility uses it, separate storage for look-alike products, restricted access to concentrated electrolytes, and a defined process for returns and recalls. Controlled substances require accurate inventory counts and record keeping under the rules of the relevant national and state agencies. In the United States, the Drug Enforcement Administration sets federal requirements, and state boards of pharmacy may add stricter rules.
• Compounding carries its own standards. In the United States, USP General Chapter 797 addresses sterile compounding and USP General Chapter 800 addresses handling of hazardous drugs. Current good manufacturing practice regulations in 21 CFR Parts 210 and 211 describe the quality system expected of drug manufacturing, and outsourcing or large-scale compounding can bring a site under those expectations, so check which framework applies to your operation. Outside the United States, confirm the rules of the local regulator and the pharmacopeia it recognizes.
• This section does not replace the judgment of a licensed pharmacist, the approved procedures of the facility, or required authorization from the prescriber or regulator. For controlled, high-risk, or sterile work, confirm current requirements with the regulator and your institution's quality team before changing a process.

06Collaboration and documentation

• Good records keep a pharmacy team working as one unit. The medication record, verification notes, compounding batch record, and counseling note should each answer a question someone will ask later: what was ordered, what was given, who checked it, and what changed. Keep entries factual and time-stamped, and correct errors by amendment rather than deletion.
• Collaboration with prescribers works best when recommendations are specific. Instead of noting that a dose seems high, state the patient's creatinine clearance, the usual adjustment range from the product labeling, and the proposed change. Accept that some recommendations will be declined, and record the reason. Nurses, technicians, and quality staff need a route to raise concerns without penalty, and the pharmacist should review each concern promptly.
• Documentation standards differ by setting and by the electronic health record in use. Where the system has structured fields, use them. Where it relies on free text, keep the same order of information in every note so a colleague can scan it quickly. Record substitutions, therapeutic interchanges, and other policy-permitted actions along with the authority under which they were taken.

07Measures and continuous improvement

• Measure what affects patient outcomes and process reliability. Useful indicators include the number of dispensing errors caught before release, the proportion of pharmacist interventions accepted by prescribers, time from order receipt to ready product, stock-out frequency for critical medicines, expired or wasted stock, beyond-use date compliance found in audits, and the number of near-miss reports filed. Set targets locally from your own baseline and risk profile rather than adopting another site's figures.
• Use a small set of indicators and review them on a fixed cycle, such as monthly at a team meeting. Pair the numbers with case review. A rise in near-miss reports can mean a better reporting culture rather than worse practice, so read trends with the people who generated the data.
• Continuous improvement follows a simple loop: identify a problem, define the change, test it on one shift or one ward, measure the result, and then decide whether to extend it. Avoid changing several processes at once, because the cause of any improvement or regression becomes unclear. Update standard operating procedures and retrain staff when a change is adopted.
• Trade-offs apply here too. A second check reduces some errors but adds delay during peak hours, so the team may need additional staffing or a risk-based rule that targets high-alert medicines first.

08Common mistakes and how to prevent them

• A frequent mistake is treating verification as a signature rather than a judgment. Prevent it by asking the verifier to state the elements checked, and by sampling completed verifications during audits.
• Look-alike and sound-alike names cause many dispensing errors. Prevent them with tall-man lettering where the facility uses it, separate storage, and a habit of confirming the strength aloud or on screen before the label is printed.
• Overlooking renal or hepatic dosing adjustments leads to avoidable harm. Keep current laboratory values visible in the workflow, and confirm the adjustment basis in the product labeling or a reliable drug reference.
• Compounding without checking stability can produce a product that loses potency or supports microbial growth. Prevent this by tying each formula to a documented stability source and assigning beyond-use dates according to the applicable standard.
• Poor handoffs at transitions of care leave patients with duplicate or omitted medicines. Prevent them with a reconciled list, a named receiving contact, and a follow-up call where the risk is high.
• Inconsistent documentation makes later review impossible. Prevent it with templates, a short set of required fields, and a rule that corrections are made by amendment.
• Crushing or opening a product that must not be altered is a quiet error. Check the administration guidance for the specific product before giving instructions to a nurse or patient.
• Staff who feel unable to speak up will stay silent about concerns. Make reporting easy, respond to reports visibly, and recognize people who catch problems early.

09Practical checklist

• Confirm patient identity with two identifiers and confirm the source of the order.
• Screen the indication, dose, route, frequency, allergies, interactions, and relevant laboratory values before verification.
• Recalculate weight-based or high-alert doses independently and record the result.
• Check the product name, strength, dosage form, and lot against the order and the label.
• Assign a beyond-use date only from a documented stability source and the applicable standard.
• Complete a final physical and label check by a second qualified person where policy requires it.
• Counsel the patient or caregiver and use teach-back for high-risk medicines.
• Document interventions, prescriber responses, and substitutions along with the authority used.
• Review the indicators monthly and update procedures when a change is adopted.

★Learning sources

• Micro Degree: Pharmacy Practice and Pharmaceutical Sciences
• Micro Degree: Healthcare Administration Practice
• Micro Degree: Physiotherapy Assistant Operations
• Micro Degree: Cardiac Care Support